Related Experiment Videos
[Use of prostate specific antigen. A review]
K Brasso1, P Skaarup, J U Roosen
1H:S Rigshospitalet, kirurgisk afdeling D.
Ugeskrift for Laeger
|August 13, 1998
Summary
Prostate specific antigen (PSA) is a valuable tumor marker for prostate cancer, but its lack of specificity limits early diagnosis. This review examines PSA
Area of Science:
- Oncology
- Biochemistry
Context:
- Prostate specific antigen (PSA) has emerged as a significant biomarker in prostate cancer management.
- Its widespread adoption reflects its perceived utility in clinical practice.
Purpose:
- To review the current applications of PSA testing in the clinical management of prostate cancer.
- To highlight the limitations of PSA in early cancer detection.
Summary:
- PSA is considered a key tumor marker for prostate cancer.
- However, its specificity is limited, impacting its effectiveness for early diagnosis.
- The review covers PSA's role in diagnosis, staging, and patient monitoring.
Impact:
- Understanding PSA's utility and limitations is crucial for accurate prostate cancer diagnosis and management.
- This review provides insights for clinicians and researchers on optimizing PSA use.